Literature DB >> 3689390

Synthesis and characterization of O6-(2-chloroethyl)guanine: a putative intermediate in the cytotoxic reaction of chloroethylnitrosoureas with DNA.

S Parker1, M C Kirk, D B Ludlum.   

Abstract

The chloroethylnitrosoureas are useful antitumor agents which evidently exert a significant part of their cytotoxic action through the formation of a unique 1-(3-deoxycytidyl), 2-(1-deoxyguanosinyl)ethane cross-link in DNA. It has been suggested that this cross-link is formed from O6-(2-chloro-ethyl)guanine, an initial product of DNA alkylation by the chloroethylnitrosoureas; however, O6-(2-chloroethyl)guanine has never been described. We have synthesized this derivative from the reaction of thionyl chloride with O6-(2-hydroxyethyl)guanine, and have found that it decomposes to 1-(2-hydroxyethyl)guanine through an intermediate, presumably 1,O6-ethanoguanine. Its half life at 37 degrees and pH 7.4 is 17.8 min.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689390     DOI: 10.1016/s0006-291x(87)80249-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Covalent capture of a human O(6)-alkylguanine alkyltransferase-DNA complex using N(1),O(6)-ethanoxanthosine, a mechanism-based crosslinker.

Authors:  D M Noll; N D Clarke
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

2.  Mechanism-based design of agents that selectively target drug-resistant glioma.

Authors:  Kingson Lin; Susan E Gueble; Ranjini K Sundaram; Eric D Huseman; Ranjit S Bindra; Seth B Herzon
Journal:  Science       Date:  2022-07-28       Impact factor: 63.714

3.  DNA alkylation products formed by 1-(2-chloroethyl)-1-nitrosourea as molecular dosimeters of therapeutic response.

Authors:  William J Bodell
Journal:  J Neurooncol       Date:  2008-11-02       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.